IFP Advisors’s BioAge Labs BIOA Stock Holding History

IFP Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221	Hold	9	–	–	﹤0.01%	4843
2026 Q1	$157	Hold	9	–	–	﹤0.01%	4660
2025 Q4	$119	Buy	9 +7	+350%	+$62	﹤0.01%	4562
2025 Q3	$12	Buy	+2	New	+$9	﹤0.01%	4781

Other funds holding BIOA

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

IFP Advisors's BIOA Position: Q2 2026 in Review

IFP Advisors held its BioAge Labs (BIOA) position steady in Q2 2026 at 9 shares worth $221. The position accounts for ﹤0.01% of the portfolio, ranked #4843.

IFP Advisors first reported a position in BIOA in Q3 2025 and has held it in 4 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

IFP Advisors held 9 shares of BioAge Labs worth $221 as of Q2 2026.
IFP Advisors left its BioAge Labs share count unchanged in Q2 2026.
BioAge Labs made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4843 holding.
IFP Advisors first reported a position in BioAge Labs in Q3 2025 and has held it in 4 quarters since.
151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.